Deborah Cromer News Today

​​Part of regular seminar series of interest to mathematical and statistical modellers, and infectious disease epidemiologists.​

Newer variant-specific bivalent vaccines offer on average 1.6 times better immunity against COVID-19 than the original, single-strain ‘ancestral’ vaccines, new research by UNSW’s Kirby institute published today in Nature Medicine shows."We’re in an i

Australia’s newest vaccine targets a variant that is no longer being detected here. The US is further ahead because it has a different approach to approvals.

COVID-19 reinfections do occur - here is what you need to know.

As the COVID-19 pandemic continues to unfold, a key piece of information for informing public health decision making is how immune the population is over time and to the latest variants. An immune marker which correlates with immunity/vaccine efficacy, such as that used for influenza, is critical for public health decision making.

Keeping you in The Loop with a quick wrap-up of today's headlines.

For an unfortunate few, COVID has struck not just once but twice, or even several times over.

Reinfections do occur - here is what you need to know.

While many assume they will be immune after catching Covid, experts say the emergence of Omicron has seen a significant increase in reinfection

The science on Omicron is starting to settle, so what does it reveal about the new dominant strain’s infectiousness, mortality and vaccine resistance.